Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk
Nature Chemical Biology2016Vol. 12(7), pp. 504–510
Citations Over TimeTop 10% of 2016 papers
Sara Sdelci, Charles-Hugues Lardeau, C. Tallant, Freya Klepsch, Björn Klaiber, James M. Bennett, Philipp Rathert, Michael Schuster, Thomas Penz, O. Fedorov, Giulio Superti‐Furga, Christoph Bock, Johannes Zuber, K. Huber, Stefan Knapp, Susanne Müller, Stefan Kubicek
Related Papers
- → PFI-1, a Highly Selective Protein Interaction Inhibitor, Targeting BET Bromodomains(2013)245 cited
- → Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734(2020)85 cited
- → Therapeutic targeting of p300/CBP HAT domain for the treatment of NUT midline carcinoma(2020)47 cited
- → CG13250, a novel bromodomain inhibitor, suppresses proliferation of multiple myeloma cells in an orthotopic mouse model(2017)17 cited
- → Data from Combined Targeting of the BRD4–NUT–p300 Axis in NUT Midline Carcinoma by Dual Selective Bromodomain Inhibitor, NEO2734(2023)